297P Real-life efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient (dMMR/MSI-H) biliary tract cancer (BTC)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.05.303
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
A. Hollebecque is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Monoclonal and Polyclonal Antibodies Research & Cancer Genomics and Diagnostics.
https://doi.org/10.1016/j.annonc.2024.05.303
https://doi.org/10.1016/j.annonc.2024.08.723
Click to start Chat